Seminar: Mark Gilligan on Commercialisation of Microfluidics

Friday, November 30th at 9AM – Room 301.242

Microfluidics and Commercial Success! Compatible or not?

A view of microfluidics applied to commercial markets and lessons to learn to improve likelihood of future success.

Mark Gilligan, Executive chairman and commercial director of Blacktrace Ltd.

Mark’s speciality is taking science and creating a commercially successful product offering. He started Syrris in August 2001 to address the challenges faced by the Pharmaceutical industry. Syrris has now grown to be a group of companies with over 40 people working in 5 countries. The Dolomite subsidiary of the Syrris Group is focussed on providing Microfluidic Solutions to customers around the world in a very wide range of applications. (www.blacktrace.com)